<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01823848</url>
  </required_header>
  <id_info>
    <org_study_id>Enema Randomization</org_study_id>
    <nct_id>NCT01823848</nct_id>
  </id_info>
  <brief_title>A Trial of Three Types of Enemas Used to Treat Functional Constipation in Children</brief_title>
  <official_title>A Randomized Controlled Trial of Three Types of Enemas Used to Treat Functional Constipation in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital Los Angeles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Functional constipation is extremely common in children and is defined as painful, hard&#xD;
      stools or firm stools for twice or less per week. Functional constipation accounts for 3% of&#xD;
      general pediatric visits and up to 25% of pediatric gastroenterology visits. Constipation and&#xD;
      fecal impaction can lead to a range of symptoms including decreased appetite, vomiting, and&#xD;
      abdominal pain frequently resulting in Emergency Department (ED) presentation. In contrast to&#xD;
      the outpatient setting where diet and oral medications work well to relieve symptoms related&#xD;
      to functional constipation, ED management requires an approach with quicker results. For&#xD;
      immediate relief of symptoms, disimpaction via enema use may be better than polyethylene&#xD;
      glycol (PEG) 3350 for children. However, the type of enema to be used is not well studied.&#xD;
      Currently, any patient presenting to the ED with a presumed diagnosis of abdominal pain due&#xD;
      to functional constipation receives an oral dose of PEG and one of the following three types&#xD;
      of enemas (based on the ED treating attending's discretion): phosphate or Fleets enema,&#xD;
      normal saline enema, or mineral oil enema. There is no evidence in the literature that&#xD;
      demonstrates any difference in the effectiveness of each of these enemas. The investigators&#xD;
      propose a randomized control trial of the three types of pediatric enemas readily used in our&#xD;
      ED to determine the best approach. There will be three arms within this study: a) PEG plus&#xD;
      phosphate enema b) PEG plus normal saline enema and c) PEG plus mineral oil enema. The&#xD;
      physicians enrolling patients will not be the treating physicians. The four principal&#xD;
      investigators (blinded to the type of enema being used), following appropriate informed&#xD;
      consent, will obtain pain scores (Faces Pain Scale - Revised) pre- and post-administration of&#xD;
      each of the three treatments listed above in order to determine the best enema to use in&#xD;
      children 4-12 years of age. Other outcomes to be analyzed will include the patient's weight&#xD;
      pre- and post-administration of the enema, satisfaction ratings on a visual analog scale from&#xD;
      the treating physician (who will also be blinded), and parental surveys on the day of&#xD;
      administration and 3-5 days following discharge. Data analysis for pain scores will be&#xD;
      completed with repeated measures anova. Categorical values will be compared using Chi Square&#xD;
      analysis and continuous variables will be compared using parametric statistics.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    insufficient staff to enroll&#xD;
  </why_stopped>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in pain scores following administration of enema</measure>
    <time_frame>1-2 hours</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Functional Constipation</condition>
  <arm_group>
    <arm_group_label>Sodium phosphate enema</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of sodium phosphate (fleets) enema for functional constipation in children ages 4-12 years Age 4-5: 33ml per rectum Age 5-12: 66ml per rectum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal saline enema</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of normal saline enema for functional constipation in children ages 4-12 years Admininstered as 10ml/kg with maximum of 700ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mineral oil enema</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administration of mineral oil enema for functional constipation in children ages 4-12 years Administered as 66ml per rectum</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium phosphate enema</intervention_name>
    <description>Rectally administered medication to treat constipation</description>
    <arm_group_label>Mineral oil enema</arm_group_label>
    <arm_group_label>Normal saline enema</arm_group_label>
    <arm_group_label>Sodium phosphate enema</arm_group_label>
    <other_name>Fleets enema</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline enema</intervention_name>
    <description>Rectally administered medication to treat constipation</description>
    <arm_group_label>Mineral oil enema</arm_group_label>
    <arm_group_label>Normal saline enema</arm_group_label>
    <arm_group_label>Sodium phosphate enema</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mineral oil enema</intervention_name>
    <description>Mineral oil enema administered to treat constipation. 66ml per rectum</description>
    <arm_group_label>Mineral oil enema</arm_group_label>
    <arm_group_label>Normal saline enema</arm_group_label>
    <arm_group_label>Sodium phosphate enema</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 4-12 years&#xD;
&#xD;
          -  Receiving enema in ED for presumed constipation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Critically ill patient&#xD;
&#xD;
          -  Any history of renal insufficiency, renal disease, or elevated creatinine&#xD;
&#xD;
          -  Any history of intestinal anatomic abnormality (i.e. anal stenosis, anal surgery,&#xD;
             bowel obstruction, hirschprung's disease)&#xD;
&#xD;
          -  An inability to self-report pain&#xD;
&#xD;
          -  Presence of gastrostomy or jejunostomy tube&#xD;
&#xD;
          -  Any history of gastrointestinal dysmotility&#xD;
&#xD;
          -  Inability to read or speak English or Spanish&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ara Festekjian, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHLA Division of Emergency Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>March 26, 2013</study_first_submitted>
  <study_first_submitted_qc>March 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2013</study_first_posted>
  <last_update_submitted>January 29, 2019</last_update_submitted>
  <last_update_submitted_qc>January 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital Los Angeles</investigator_affiliation>
    <investigator_full_name>Ara Festekjian</investigator_full_name>
    <investigator_title>Assistant Professor of Clinical Pediatrics</investigator_title>
  </responsible_party>
  <keyword>constipation</keyword>
  <keyword>enema</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mineral Oil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

